ロード中...
Adjuvant Chemotherapy for Stage III Colon Cancer
SIMPLE SUMMARY: In patients with stage III colon cancer, adjuvant chemotherapy with a fluoropyrimidine combined with oxaliplatin reduces the risk of recurrence and mortality, with a treatment duration that may be shortened from 6 to 3 months in certain situations allowing to limit toxicities, especi...
保存先:
| 出版年: | Cancers (Basel) |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7564362/ https://ncbi.nlm.nih.gov/pubmed/32961795 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12092679 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|